openPR Logo
Press release

Prefilled Syringes Market

06-28-2017 04:57 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Parenteral drugs are the second most preferred type of drugs after oral solid dosage forms and also holds second largest market share in terms of revenue in overall pharmaceutical market. Various benefits such as ease in administration, better patient compliance and 100% bioavailability are the few important factors that are expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Prefilled syringes segment is the one of the most important of the parenteral products market. However, volume sales in the market is rather low as it is a fairly novel product. The market is expected to gain traction over the forecast period, with increasing number of products and growing awareness among the populace about the benefits of the product. There are various factors such as ease in administration and minimum contact with the exposed environment that are expected to favor growth of the prefilled syringes market in the near future. Use of syringes with prefilled drugs would be especially useful in emergency situations. According to Drug Development & Delivery, around 3.5 billion of prefilled syringes are produced each year and the existing numbers are expected to grow by the rate of around 9.0 – 10% annually.

Request a sample copy of this report@
https://www.coherentmarketinsights.com/insight/request-sample/162

Prefilled Syringes market taxonomy:

By Application

Monoclonal Antibodies
Vaccines
Others
By Material Type

Polymer
PVC
Cyclo-olefin Polymer(COP)
Glass
By Design

Single Chambered
Dual Chambered
Multi-Chambered
Rising demand for biologics and self-injection products to augment market growth

A large number of newly approved biologics and drugs demand for PFS delivery devices for the subcutaneous (SC) self-injection of biopharmaceuticals. Also, the need for simpler self-injection procedures and improved patient compliance for auto injectors, large-volume patch injectors and pens is on the rise. This in turn is expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Patient exposure towards the routine injection can affect patient compliance, as it can cause significant discomfort to the user. Introduction of large volume biologics though, have helped rise in adoption rate of prefilled syringes. This in turn is expected to favor the market over the forecast period. Some factors such as growth in adoption of injectable drugs, success and growth of biologics, increased global vaccination, increased drug self-administration trend, technological advancements in the manufacture of PFS, and development of advanced PFS would further augment market growth.

Rise in number of applications is to favor the expansion of global prefilled syringes market:

Prefilled syringes market is expanding rapidly globally due to its various applications in overall healthcare sector. Nowadays, PFS manufacturing companies are focused on promoting use of the product in various application especially in homecare settings, which further is projected to favor increase in customer base in various regions. Furthermore, manufacturers are working towards developing PFS vaccines to help in indications such as various infectious disease and cancer. PFS are also being efficiently used in emergency medical services and in emergency section of hospitals. According to Frederick Furness Publishing Ltd, around 70% of atropine syringes prepared by the hospital staff are pre-filled and can be immediately used in emergency conditions.

Highly consolidated market is expected to favor the sales revenue of prefilled syringes market:

There are around 20 pharmaceutical companies that are involved in manufacturing and marketing of prefilled syringes as preferred delivery device of around 50 injectable drugs and vaccines, which contributes significantly to the sales revenue of these players. Furthermore, there are few recent acquisitions by the big brands in market of prefilled syringes such as in 2012, Becton Dickinson and Company acquired Safety Syringes, Inc., which is further expected to favor the company’s syringes manufacturing efficiency and increase its product portfolio. Key players operating in the prefilled syringes market include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group, and Terumo Corporation

Get More Details about this Report@
https://www.coherentmarketinsights.com/ongoing-insight/prefilled-syringes-market-162

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prefilled Syringes Market here

News-ID: 599618 • Views: 216

More Releases from Pharmaceutical Report By CMI

Rising prevalence of diabetes is a major factor driving growth of the diabetic f …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the
Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Increasing prevalence of multiple sclerosis to augment market growth Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, 2017, this autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year. The study also states that prevalence rates varies between ethnic and geographical latitudes, ranging from 50 to
Diabetic Foot Ulcers Treatment Market to Surpass US$ 9.49 Billion Threshold by 2 …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the

All 5 Releases


More Releases for PFS

PFS Rubber Stopper 2019 Global Market Outlook, Research, Trends and Forecast to …
PFS Rubber Stopper Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/104512 UpMarketResearch offers a latest published report on “Global PFS Rubber Stopper Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive
Meet top PFS experts, network with 100+ pharma and biotech industry leaders next …
SMi Group reports: Last call for registrations to Pre-Filled Syringes East Coast conference SMi’s global portfolio of events on Pre-Filled Syringes secured an audience of over 300 senior drug delivery and medical device experts over the last year. Next week, April 8 – 9, in Boston, will be held the 6th annual Pre-Filled Syringes East Coast conference and exhibition where industry leaders from pharmaceutical, biotech and device manufacturing, meet to get
PFS Development – challenges and solutions, Pre-Filled Syringes East Coast is …
Despite lucrative opportunities in the PFS industry, there are a few ongoing challenges that the key-leaders battle to overcome, including human factor considerations, new laws, user interface considerations and patient safety. SMi’s Pre-Filled Syringes East Coast Conference (8 - 9 April, Boston, US) is a place to debate these issues, engage with experts and determine strategy. One of the main features of the event will be what the future of
Hear from PFS industry leaders from big pharma, government bodies & top manufact …
SMi Reports: 11th Annual Conference and Exhibition on Pre-Filled Syringes & Injectable Drug Devices will take place in just over a months’ time on the 16th-17th January 2019 in London. This premium event will feature over 100 selected senior pre-filled syringes experts from leading PFS markets, including Austria, Belgium, Finland, France, Germany, Japan, Switzerland, UK, USA and many other countries. Event attendees will gather to discuss solutions to accelerate PFS
Parenteral drug delivery: optimizing and developing novel methods in PFS industr …
Pre-Filled Syringes West Coast: SMi Groups latest instalment in the industry renowned Pre-Filled Syringes global event series welcoming industry leaders this June in San Diego, USA The conference programme is tailored around industry needs and is packed with market-led case studies offering progressive insight into parenteral drug delivery. Pre-Filled Syringes West Coast show is taking place on June 4 – 5 in San Diego, CA with an additional day (June 6
Future of PFS injection devices from cross-industry expertise perspectives – d …
With just over a month away, SMi's Pre-Filled Syringes West Coast show (June 4 - 5, San Diego, CA) is set to beat the record in attendee interest. Set to attend the event are: AbbVie, Allergan, Amgen, Antares Pharma, Aptar Pharma, Baxter Healthcare, Boehringer Ingelheim, Credence MedSystems, Ferring Pharmaceuticals, Genentech, Gilead Science, Glenmark Pharmaceuticals, Ionis Pharmaceuticals, Merck & Co., Novo Nordisk, Pfizer, Regeneron, Shire, Xeris Pharmaceuticals, amongst others. Visit Pre-Filled